Industry Research Reports

Home > Reports > Service & Software > AI Drug Target Discovery Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

AI Drug Target Discovery Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-07-02

Pages: 159 Pages

Report ld: 4651137

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

AI Drug Target Discovery Service Market Size(US$)

CAGR 2025-2031

23.0%

Market Size,2031

USD 14,186

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 4,097 million

Market Forecast in 2031(Value)

US$ 14,186 million

CAGR

23.0%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for AI Drug Target Discovery Service was estimated to be worth US$ 3394 million in 2024 and is forecast to a readjusted size of US$ 14186 million by 2031 with a CAGR of 23.0% during the forecast period 2025-2031.

AI Drug Target Discovery Service refers to a method that uses artificial intelligence technology to identify, validate and screen potential drug targets. By analyzing and mining massive biomedical data, this method uses machine learning, deep learning and other algorithms to predict and identify disease-related biomolecules, which can be used as targets for drug development, thereby accelerating the process of new drug discovery and research and development.

Market Opportunities and Key Drivers:

The AI Drug Target Discovery Service is experiencing unprecedented growth opportunities, with the core driving forces stemming from the triple resonance of technological innovation, policy support, and market demand. This growth is attributed to the disruptive impact of AI technology on the efficiency of drug development: traditional target discovery takes 5-7 years, while AI algorithms can shorten the cycle to 1-2 years, reducing the research cost by 40%-60%, and increasing the success rate of preclinical target validation from less than 10% to over 25%. At the policy level, China's "14th Five-Year Plan" has designated AI pharmaceuticals as a key development area, and the US FDA has also launched an "AI Priority" fast-track approval channel to accelerate the entry of AI-discovered targets into clinical trials. At the market demand end, the explosive growth in the treatment needs for chronic diseases and rare diseases has become the core driving force - for instance, AI successfully identified PD-L1's drug resistance mechanism-derived targets (such as LAG-3) in tumor target discovery, promoting the iteration of immunotherapy; in the rare disease field, AI analyzed the data from the 10,000 Genomes Project to identify new targets such as SMN2 enhancer for SMA (spinal muscular atrophy), filling the gaps in traditional research. Additionally, the capital enthusiasm continues to rise: in 2024, the global financing in the AI pharmaceutical field exceeded 12 billion US dollars, with target discovery enterprises accounting for 35% (such as Insilico Medicine, Exscientia, etc.), and pharmaceutical giants such as Eli Lilly and Roche have deeply invested in AI target platforms through cooperation or acquisition, further catalyzing industry expansion.

Challenges and Future Directions:

The AI Drug Target Discovery Service still faces multiple challenges in terms of data, technology, and ethics. The primary data bottleneck is the foremost issue: the fragmentation of biomedical data and privacy barriers lead to a lack of high-quality training data, for example, only 15% of protein interaction data related to target association meet the requirements of AI models, and the anonymization of patient genetic data weakens the accuracy of target prediction. The insufficient technical maturity also restricts application: deep learning models have poor explainability in predicting target mechanisms (the "black box problem"), resulting in 30% of AI predicted targets being unable to be verified through wet experiments; at the same time, the shortage of interdisciplinary talents separates algorithm development from biological validation, prolonging the transformation cycle. The regulatory and ethical risks are equally prominent: there are no unified standards for the intellectual property rights of AI-generated targets in various countries (such as whether AI can be listed as an inventor of a patent), and algorithm biases may ignore the characteristics of specific populations (such as the missing rate of genetic variation data for African Americans reaching 40%), exacerbating medical inequality. The future direction will focus on technology integration and ecosystem reconstruction: on the one hand, multimodal AI models (such as AlphaFold 3 combined with structure prediction and molecular dynamics simulation) can improve the accuracy of target screening, while quantum computing will solve the computational bottleneck of protein folding simulation; on the other hand, federated learning technology can integrate cross-border medical data under privacy protection, building a "global brain" for target discovery. At the industry level, the "AI + CRO" model (such as the collaboration between Wuxi Chemtech and Insilico) will promote the large-scale validation of targets, and blockchain technology may establish new standards for target data traceability and intellectual property rights confirmation. Ultimately, AI target discovery will evolve from a tool to a platform ecosystem, achieving a paradigm shift from "single-target breakthrough" to "disease network targeting" through open collaboration.

This report aims to provide a comprehensive presentation of the global market for AI Drug Target Discovery Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI Drug Target Discovery Service by region & country, by Type, and by Application.

The AI Drug Target Discovery Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Drug Target Discovery Service.

MARKET SEGMENTATION

By Company

Exscientia
Atomwise
Benevolent AI
Insitro
Xaira Therapeutics
Tempus AI
AbCellera
Recursion
Iktos
Genialis
Anima Biotech
BPGbio
Cradle
Isomorphic Labs
Generate Biomedicines
Latent Labs
Relay Therapeutics
Model Medicines
Nimbus Therapeutics
Schrödinger
XtalPi
Insilico Medicine
Drug Farm
BioMap

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Target Identification Based on Omics Data and Biological Networks
Target Mining Based on Literature and Knowledge Graphs
Target Prediction Based on Structural Bioinformatics
Target Discovery Based on Phenotypic Screening and Virtual Patients

Segment by Application

Pharmaceutical Company
CRO and Universities
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of AI Drug Target Discovery Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of AI Drug Target Discovery Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of AI Drug Target Discovery Service in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 AI Drug Target Discovery Service Product Introduction

1.2 Global AI Drug Target Discovery Service Market Size Forecast (2020-2031)

1.3 AI Drug Target Discovery Service Market Trends & Drivers

1.3.1 AI Drug Target Discovery Service Industry Trends

1.3.2 AI Drug Target Discovery Service Market Drivers & Opportunity

1.3.3 AI Drug Target Discovery Service Market Challenges

1.3.4 AI Drug Target Discovery Service Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global AI Drug Target Discovery Service Players Revenue Ranking (2024)

2.2 Global AI Drug Target Discovery Service Revenue by Company (2020-2025)

2.3 Key Companies AI Drug Target Discovery Service Manufacturing Base Distribution and Headquarters

2.4 Key Companies AI Drug Target Discovery Service Product Offered

2.5 Key Companies Time to Begin Mass Production of AI Drug Target Discovery Service

2.6 AI Drug Target Discovery Service Market Competitive Analysis

2.6.1 AI Drug Target Discovery Service Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by AI Drug Target Discovery Service Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Target Discovery Service as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Target Identification Based on Omics Data and Biological Networks

3.1.2 Target Mining Based on Literature and Knowledge Graphs

3.1.3 Target Prediction Based on Structural Bioinformatics

3.1.4 Target Discovery Based on Phenotypic Screening and Virtual Patients

3.2 Global AI Drug Target Discovery Service Sales Value by Type

3.2.1 Global AI Drug Target Discovery Service Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global AI Drug Target Discovery Service Sales Value, by Type (2020-2031)

3.2.3 Global AI Drug Target Discovery Service Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pharmaceutical Company

4.1.2 CRO and Universities

4.1.3 Others

4.2 Global AI Drug Target Discovery Service Sales Value by Application

4.2.1 Global AI Drug Target Discovery Service Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global AI Drug Target Discovery Service Sales Value, by Application (2020-2031)

4.2.3 Global AI Drug Target Discovery Service Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global AI Drug Target Discovery Service Sales Value by Region

5.1.1 Global AI Drug Target Discovery Service Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global AI Drug Target Discovery Service Sales Value by Region (2020-2025)

5.1.3 Global AI Drug Target Discovery Service Sales Value by Region (2026-2031)

5.1.4 Global AI Drug Target Discovery Service Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America AI Drug Target Discovery Service Sales Value, 2020-2031

5.2.2 North America AI Drug Target Discovery Service Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe AI Drug Target Discovery Service Sales Value, 2020-2031

5.3.2 Europe AI Drug Target Discovery Service Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific AI Drug Target Discovery Service Sales Value, 2020-2031

5.4.2 Asia Pacific AI Drug Target Discovery Service Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America AI Drug Target Discovery Service Sales Value, 2020-2031

5.5.2 South America AI Drug Target Discovery Service Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa AI Drug Target Discovery Service Sales Value, 2020-2031

5.6.2 Middle East & Africa AI Drug Target Discovery Service Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions AI Drug Target Discovery Service Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions AI Drug Target Discovery Service Sales Value, 2020-2031

6.3 United States

6.3.1 United States AI Drug Target Discovery Service Sales Value, 2020-2031

6.3.2 United States AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

6.3.3 United States AI Drug Target Discovery Service Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe AI Drug Target Discovery Service Sales Value, 2020-2031

6.4.2 Europe AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe AI Drug Target Discovery Service Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China AI Drug Target Discovery Service Sales Value, 2020-2031

6.5.2 China AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

6.5.3 China AI Drug Target Discovery Service Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan AI Drug Target Discovery Service Sales Value, 2020-2031

6.6.2 Japan AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan AI Drug Target Discovery Service Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea AI Drug Target Discovery Service Sales Value, 2020-2031

6.7.2 South Korea AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea AI Drug Target Discovery Service Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia AI Drug Target Discovery Service Sales Value, 2020-2031

6.8.2 Southeast Asia AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia AI Drug Target Discovery Service Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India AI Drug Target Discovery Service Sales Value, 2020-2031

6.9.2 India AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

6.9.3 India AI Drug Target Discovery Service Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Exscientia

7.1.1 Exscientia Profile

7.1.2 Exscientia Main Business

7.1.3 Exscientia AI Drug Target Discovery Service Products, Services and Solutions

7.1.4 Exscientia AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.1.5 Exscientia Recent Developments

7.2 Atomwise

7.2.1 Atomwise Profile

7.2.2 Atomwise Main Business

7.2.3 Atomwise AI Drug Target Discovery Service Products, Services and Solutions

7.2.4 Atomwise AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.2.5 Atomwise Recent Developments

7.3 Benevolent AI

7.3.1 Benevolent AI Profile

7.3.2 Benevolent AI Main Business

7.3.3 Benevolent AI AI Drug Target Discovery Service Products, Services and Solutions

7.3.4 Benevolent AI AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.3.5 Benevolent AI Recent Developments

7.4 Insitro

7.4.1 Insitro Profile

7.4.2 Insitro Main Business

7.4.3 Insitro AI Drug Target Discovery Service Products, Services and Solutions

7.4.4 Insitro AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.4.5 Insitro Recent Developments

7.5 Xaira Therapeutics

7.5.1 Xaira Therapeutics Profile

7.5.2 Xaira Therapeutics Main Business

7.5.3 Xaira Therapeutics AI Drug Target Discovery Service Products, Services and Solutions

7.5.4 Xaira Therapeutics AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.5.5 Xaira Therapeutics Recent Developments

7.6 Tempus AI

7.6.1 Tempus AI Profile

7.6.2 Tempus AI Main Business

7.6.3 Tempus AI AI Drug Target Discovery Service Products, Services and Solutions

7.6.4 Tempus AI AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.6.5 Tempus AI Recent Developments

7.7 AbCellera

7.7.1 AbCellera Profile

7.7.2 AbCellera Main Business

7.7.3 AbCellera AI Drug Target Discovery Service Products, Services and Solutions

7.7.4 AbCellera AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.7.5 AbCellera Recent Developments

7.8 Recursion

7.8.1 Recursion Profile

7.8.2 Recursion Main Business

7.8.3 Recursion AI Drug Target Discovery Service Products, Services and Solutions

7.8.4 Recursion AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.8.5 Recursion Recent Developments

7.9 Iktos

7.9.1 Iktos Profile

7.9.2 Iktos Main Business

7.9.3 Iktos AI Drug Target Discovery Service Products, Services and Solutions

7.9.4 Iktos AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.9.5 Iktos Recent Developments

7.10 Genialis

7.10.1 Genialis Profile

7.10.2 Genialis Main Business

7.10.3 Genialis AI Drug Target Discovery Service Products, Services and Solutions

7.10.4 Genialis AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.10.5 Genialis Recent Developments

7.11 Anima Biotech

7.11.1 Anima Biotech Profile

7.11.2 Anima Biotech Main Business

7.11.3 Anima Biotech AI Drug Target Discovery Service Products, Services and Solutions

7.11.4 Anima Biotech AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.11.5 Anima Biotech Recent Developments

7.12 BPGbio

7.12.1 BPGbio Profile

7.12.2 BPGbio Main Business

7.12.3 BPGbio AI Drug Target Discovery Service Products, Services and Solutions

7.12.4 BPGbio AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.12.5 BPGbio Recent Developments

7.13 Cradle

7.13.1 Cradle Profile

7.13.2 Cradle Main Business

7.13.3 Cradle AI Drug Target Discovery Service Products, Services and Solutions

7.13.4 Cradle AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.13.5 Cradle Recent Developments

7.14 Isomorphic Labs

7.14.1 Isomorphic Labs Profile

7.14.2 Isomorphic Labs Main Business

7.14.3 Isomorphic Labs AI Drug Target Discovery Service Products, Services and Solutions

7.14.4 Isomorphic Labs AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.14.5 Isomorphic Labs Recent Developments

7.15 Generate Biomedicines

7.15.1 Generate Biomedicines Profile

7.15.2 Generate Biomedicines Main Business

7.15.3 Generate Biomedicines AI Drug Target Discovery Service Products, Services and Solutions

7.15.4 Generate Biomedicines AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.15.5 Generate Biomedicines Recent Developments

7.16 Latent Labs

7.16.1 Latent Labs Profile

7.16.2 Latent Labs Main Business

7.16.3 Latent Labs AI Drug Target Discovery Service Products, Services and Solutions

7.16.4 Latent Labs AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.16.5 Latent Labs Recent Developments

7.17 Relay Therapeutics

7.17.1 Relay Therapeutics Profile

7.17.2 Relay Therapeutics Main Business

7.17.3 Relay Therapeutics AI Drug Target Discovery Service Products, Services and Solutions

7.17.4 Relay Therapeutics AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.17.5 Relay Therapeutics Recent Developments

7.18 Model Medicines

7.18.1 Model Medicines Profile

7.18.2 Model Medicines Main Business

7.18.3 Model Medicines AI Drug Target Discovery Service Products, Services and Solutions

7.18.4 Model Medicines AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.18.5 Model Medicines Recent Developments

7.19 Nimbus Therapeutics

7.19.1 Nimbus Therapeutics Profile

7.19.2 Nimbus Therapeutics Main Business

7.19.3 Nimbus Therapeutics AI Drug Target Discovery Service Products, Services and Solutions

7.19.4 Nimbus Therapeutics AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.19.5 Nimbus Therapeutics Recent Developments

7.20 Schrödinger

7.20.1 Schrödinger Profile

7.20.2 Schrödinger Main Business

7.20.3 Schrödinger AI Drug Target Discovery Service Products, Services and Solutions

7.20.4 Schrödinger AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.20.5 Schrödinger Recent Developments

7.21 XtalPi

7.21.1 XtalPi Profile

7.21.2 XtalPi Main Business

7.21.3 XtalPi AI Drug Target Discovery Service Products, Services and Solutions

7.21.4 XtalPi AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.21.5 XtalPi Recent Developments

7.22 Insilico Medicine

7.22.1 Insilico Medicine Profile

7.22.2 Insilico Medicine Main Business

7.22.3 Insilico Medicine AI Drug Target Discovery Service Products, Services and Solutions

7.22.4 Insilico Medicine AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.22.5 Insilico Medicine Recent Developments

7.23 Drug Farm

7.23.1 Drug Farm Profile

7.23.2 Drug Farm Main Business

7.23.3 Drug Farm AI Drug Target Discovery Service Products, Services and Solutions

7.23.4 Drug Farm AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.23.5 Drug Farm Recent Developments

7.24 BioMap

7.24.1 BioMap Profile

7.24.2 BioMap Main Business

7.24.3 BioMap AI Drug Target Discovery Service Products, Services and Solutions

7.24.4 BioMap AI Drug Target Discovery Service Revenue (US$ Million) & (2020-2025)

7.24.5 BioMap Recent Developments

8 Industry Chain Analysis

8.1 AI Drug Target Discovery Service Industrial Chain

8.2 AI Drug Target Discovery Service Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 AI Drug Target Discovery Service Sales Model

8.5.2 Sales Channel

8.5.3 AI Drug Target Discovery Service Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. AI Drug Target Discovery Service Market Trends

Table 2. AI Drug Target Discovery Service Market Drivers & Opportunity

Table 3. AI Drug Target Discovery Service Market Challenges

Table 4. AI Drug Target Discovery Service Market Restraints

Table 5. Global AI Drug Target Discovery Service Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global AI Drug Target Discovery Service Revenue Market Share by Company (2020-2025)

Table 7. Key Companies AI Drug Target Discovery Service Manufacturing Base Distribution and Headquarters

Table 8. Key Companies AI Drug Target Discovery Service Product Type

Table 9. Key Companies Time to Begin Mass Production of AI Drug Target Discovery Service

Table 10. Global AI Drug Target Discovery Service Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Target Discovery Service as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global AI Drug Target Discovery Service Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global AI Drug Target Discovery Service Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global AI Drug Target Discovery Service Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global AI Drug Target Discovery Service Sales Market Share in Value by Type (2020-2025)

Table 17. Global AI Drug Target Discovery Service Sales Market Share in Value by Type (2026-2031)

Table 18. Global AI Drug Target Discovery Service Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global AI Drug Target Discovery Service Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global AI Drug Target Discovery Service Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global AI Drug Target Discovery Service Sales Market Share in Value by Application (2020-2025)

Table 22. Global AI Drug Target Discovery Service Sales Market Share in Value by Application (2026-2031)

Table 23. Global AI Drug Target Discovery Service Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global AI Drug Target Discovery Service Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global AI Drug Target Discovery Service Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global AI Drug Target Discovery Service Sales Value by Region (2020-2025) & (%)

Table 27. Global AI Drug Target Discovery Service Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions AI Drug Target Discovery Service Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions AI Drug Target Discovery Service Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions AI Drug Target Discovery Service Sales Value, (2026-2031) & (US$ Million)

Table 31. Exscientia Basic Information List

Table 32. Exscientia Description and Business Overview

Table 33. Exscientia AI Drug Target Discovery Service Products, Services and Solutions

Table 34. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Exscientia (2020-2025)

Table 35. Exscientia Recent Developments

Table 36. Atomwise Basic Information List

Table 37. Atomwise Description and Business Overview

Table 38. Atomwise AI Drug Target Discovery Service Products, Services and Solutions

Table 39. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Atomwise (2020-2025)

Table 40. Atomwise Recent Developments

Table 41. Benevolent AI Basic Information List

Table 42. Benevolent AI Description and Business Overview

Table 43. Benevolent AI AI Drug Target Discovery Service Products, Services and Solutions

Table 44. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Benevolent AI (2020-2025)

Table 45. Benevolent AI Recent Developments

Table 46. Insitro Basic Information List

Table 47. Insitro Description and Business Overview

Table 48. Insitro AI Drug Target Discovery Service Products, Services and Solutions

Table 49. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Insitro (2020-2025)

Table 50. Insitro Recent Developments

Table 51. Xaira Therapeutics Basic Information List

Table 52. Xaira Therapeutics Description and Business Overview

Table 53. Xaira Therapeutics AI Drug Target Discovery Service Products, Services and Solutions

Table 54. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Xaira Therapeutics (2020-2025)

Table 55. Xaira Therapeutics Recent Developments

Table 56. Tempus AI Basic Information List

Table 57. Tempus AI Description and Business Overview

Table 58. Tempus AI AI Drug Target Discovery Service Products, Services and Solutions

Table 59. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Tempus AI (2020-2025)

Table 60. Tempus AI Recent Developments

Table 61. AbCellera Basic Information List

Table 62. AbCellera Description and Business Overview

Table 63. AbCellera AI Drug Target Discovery Service Products, Services and Solutions

Table 64. Revenue (US$ Million) in AI Drug Target Discovery Service Business of AbCellera (2020-2025)

Table 65. AbCellera Recent Developments

Table 66. Recursion Basic Information List

Table 67. Recursion Description and Business Overview

Table 68. Recursion AI Drug Target Discovery Service Products, Services and Solutions

Table 69. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Recursion (2020-2025)

Table 70. Recursion Recent Developments

Table 71. Iktos Basic Information List

Table 72. Iktos Description and Business Overview

Table 73. Iktos AI Drug Target Discovery Service Products, Services and Solutions

Table 74. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Iktos (2020-2025)

Table 75. Iktos Recent Developments

Table 76. Genialis Basic Information List

Table 77. Genialis Description and Business Overview

Table 78. Genialis AI Drug Target Discovery Service Products, Services and Solutions

Table 79. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Genialis (2020-2025)

Table 80. Genialis Recent Developments

Table 81. Anima Biotech Basic Information List

Table 82. Anima Biotech Description and Business Overview

Table 83. Anima Biotech AI Drug Target Discovery Service Products, Services and Solutions

Table 84. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Anima Biotech (2020-2025)

Table 85. Anima Biotech Recent Developments

Table 86. BPGbio Basic Information List

Table 87. BPGbio Description and Business Overview

Table 88. BPGbio AI Drug Target Discovery Service Products, Services and Solutions

Table 89. Revenue (US$ Million) in AI Drug Target Discovery Service Business of BPGbio (2020-2025)

Table 90. BPGbio Recent Developments

Table 91. Cradle Basic Information List

Table 92. Cradle Description and Business Overview

Table 93. Cradle AI Drug Target Discovery Service Products, Services and Solutions

Table 94. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Cradle (2020-2025)

Table 95. Cradle Recent Developments

Table 96. Isomorphic Labs Basic Information List

Table 97. Isomorphic Labs Description and Business Overview

Table 98. Isomorphic Labs AI Drug Target Discovery Service Products, Services and Solutions

Table 99. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Isomorphic Labs (2020-2025)

Table 100. Isomorphic Labs Recent Developments

Table 101. Generate Biomedicines Basic Information List

Table 102. Generate Biomedicines Description and Business Overview

Table 103. Generate Biomedicines AI Drug Target Discovery Service Products, Services and Solutions

Table 104. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Generate Biomedicines (2020-2025)

Table 105. Generate Biomedicines Recent Developments

Table 106. Latent Labs Basic Information List

Table 107. Latent Labs Description and Business Overview

Table 108. Latent Labs AI Drug Target Discovery Service Products, Services and Solutions

Table 109. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Latent Labs (2020-2025)

Table 110. Latent Labs Recent Developments

Table 111. Relay Therapeutics Basic Information List

Table 112. Relay Therapeutics Description and Business Overview

Table 113. Relay Therapeutics AI Drug Target Discovery Service Products, Services and Solutions

Table 114. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Relay Therapeutics (2020-2025)

Table 115. Relay Therapeutics Recent Developments

Table 116. Model Medicines Basic Information List

Table 117. Model Medicines Description and Business Overview

Table 118. Model Medicines AI Drug Target Discovery Service Products, Services and Solutions

Table 119. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Model Medicines (2020-2025)

Table 120. Model Medicines Recent Developments

Table 121. Nimbus Therapeutics Basic Information List

Table 122. Nimbus Therapeutics Description and Business Overview

Table 123. Nimbus Therapeutics AI Drug Target Discovery Service Products, Services and Solutions

Table 124. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Nimbus Therapeutics (2020-2025)

Table 125. Nimbus Therapeutics Recent Developments

Table 126. Schrödinger Basic Information List

Table 127. Schrödinger Description and Business Overview

Table 128. Schrödinger AI Drug Target Discovery Service Products, Services and Solutions

Table 129. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Schrödinger (2020-2025)

Table 130. Schrödinger Recent Developments

Table 131. XtalPi Basic Information List

Table 132. XtalPi Description and Business Overview

Table 133. XtalPi AI Drug Target Discovery Service Products, Services and Solutions

Table 134. Revenue (US$ Million) in AI Drug Target Discovery Service Business of XtalPi (2020-2025)

Table 135. XtalPi Recent Developments

Table 136. Insilico Medicine Basic Information List

Table 137. Insilico Medicine Description and Business Overview

Table 138. Insilico Medicine AI Drug Target Discovery Service Products, Services and Solutions

Table 139. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Insilico Medicine (2020-2025)

Table 140. Insilico Medicine Recent Developments

Table 141. Drug Farm Basic Information List

Table 142. Drug Farm Description and Business Overview

Table 143. Drug Farm AI Drug Target Discovery Service Products, Services and Solutions

Table 144. Revenue (US$ Million) in AI Drug Target Discovery Service Business of Drug Farm (2020-2025)

Table 145. Drug Farm Recent Developments

Table 146. BioMap Basic Information List

Table 147. BioMap Description and Business Overview

Table 148. BioMap AI Drug Target Discovery Service Products, Services and Solutions

Table 149. Revenue (US$ Million) in AI Drug Target Discovery Service Business of BioMap (2020-2025)

Table 150. BioMap Recent Developments

Table 151. Key Raw Materials Lists

Table 152. Raw Materials Key Suppliers Lists

Table 153. AI Drug Target Discovery Service Downstream Customers

Table 154. AI Drug Target Discovery Service Distributors List

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

List of Figures

Figure 1. AI Drug Target Discovery Service Product Picture

Figure 2. Global AI Drug Target Discovery Service Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global AI Drug Target Discovery Service Sales Value (2020-2031) & (US$ Million)

Figure 4. AI Drug Target Discovery Service Report Years Considered

Figure 5. Global AI Drug Target Discovery Service Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by AI Drug Target Discovery Service Revenue in 2024

Figure 7. AI Drug Target Discovery Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Target Identification Based on Omics Data and Biological Networks Picture

Figure 9. Target Mining Based on Literature and Knowledge Graphs Picture

Figure 10. Target Prediction Based on Structural Bioinformatics Picture

Figure 11. Target Discovery Based on Phenotypic Screening and Virtual Patients Picture

Figure 12. Global AI Drug Target Discovery Service Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 13. Global AI Drug Target Discovery Service Sales Value Market Share by Type, 2024 & 2031

Figure 14. Product Picture of Pharmaceutical Company

Figure 15. Product Picture of CRO and Universities

Figure 16. Product Picture of Others

Figure 17. Global AI Drug Target Discovery Service Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 18. Global AI Drug Target Discovery Service Sales Value Market Share by Application, 2024 & 2031

Figure 19. North America AI Drug Target Discovery Service Sales Value (2020-2031) & (US$ Million)

Figure 20. North America AI Drug Target Discovery Service Sales Value by Country (%), 2024 VS 2031

Figure 21. Europe AI Drug Target Discovery Service Sales Value, (2020-2031) & (US$ Million)

Figure 22. Europe AI Drug Target Discovery Service Sales Value by Country (%), 2024 VS 2031

Figure 23. Asia Pacific AI Drug Target Discovery Service Sales Value, (2020-2031) & (US$ Million)

Figure 24. Asia Pacific AI Drug Target Discovery Service Sales Value by Region (%), 2024 VS 2031

Figure 25. South America AI Drug Target Discovery Service Sales Value, (2020-2031) & (US$ Million)

Figure 26. South America AI Drug Target Discovery Service Sales Value by Country (%), 2024 VS 2031

Figure 27. Middle East & Africa AI Drug Target Discovery Service Sales Value, (2020-2031) & (US$ Million)

Figure 28. Middle East & Africa AI Drug Target Discovery Service Sales Value by Country (%), 2024 VS 2031

Figure 29. Key Countries/Regions AI Drug Target Discovery Service Sales Value (%), (2020-2031)

Figure 30. United States AI Drug Target Discovery Service Sales Value, (2020-2031) & (US$ Million)

Figure 31. United States AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

Figure 32. United States AI Drug Target Discovery Service Sales Value by Application (%), 2024 VS 2031

Figure 33. Europe AI Drug Target Discovery Service Sales Value, (2020-2031) & (US$ Million)

Figure 34. Europe AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

Figure 35. Europe AI Drug Target Discovery Service Sales Value by Application (%), 2024 VS 2031

Figure 36. China AI Drug Target Discovery Service Sales Value, (2020-2031) & (US$ Million)

Figure 37. China AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

Figure 38. China AI Drug Target Discovery Service Sales Value by Application (%), 2024 VS 2031

Figure 39. Japan AI Drug Target Discovery Service Sales Value, (2020-2031) & (US$ Million)

Figure 40. Japan AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

Figure 41. Japan AI Drug Target Discovery Service Sales Value by Application (%), 2024 VS 2031

Figure 42. South Korea AI Drug Target Discovery Service Sales Value, (2020-2031) & (US$ Million)

Figure 43. South Korea AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

Figure 44. South Korea AI Drug Target Discovery Service Sales Value by Application (%), 2024 VS 2031

Figure 45. Southeast Asia AI Drug Target Discovery Service Sales Value, (2020-2031) & (US$ Million)

Figure 46. Southeast Asia AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

Figure 47. Southeast Asia AI Drug Target Discovery Service Sales Value by Application (%), 2024 VS 2031

Figure 48. India AI Drug Target Discovery Service Sales Value, (2020-2031) & (US$ Million)

Figure 49. India AI Drug Target Discovery Service Sales Value by Type (%), 2024 VS 2031

Figure 50. India AI Drug Target Discovery Service Sales Value by Application (%), 2024 VS 2031

Figure 51. AI Drug Target Discovery Service Industrial Chain

Figure 52. AI Drug Target Discovery Service Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of AI Drug Target Discovery Service in 2031? zhanKai

The global market size of AI Drug Target Discovery Service in 2031 was 14186 Million USD.

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global AI Drug Target Discovery Service market size from 2025 to 2031? shouQi

Which companies rank high in the global AI Drug Target Discovery Service market? shouQi

What was the global market size of AI Drug Target Discovery Service in 2025? shouQi

Related Reports

Global AI Drug Target Discovery Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI Drug Target Discovery Service market is projected to grow from US$ 4097 million in 2025 to US$ 17120 million by 2032, at a CAGR of 23.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-24
Pages: 170
USD 4900.00
(Single User License)
Global AI Drug Target Discovery Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Drug Target Discovery Service market size was US$ 4097 million in 2025 and is forecast to reach a readjusted size of US$ 17120 million by 2032 with a CAGR of 23.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 114
USD 4250.00
(Single User License)
AI Drug Target Discovery Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Drug Target Discovery Service was estimated to be worth US$ 4097 million in 2025 and is projected to reach US$ 17120 million, growing at a CAGR of 23.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 141
USD 3950.00
(Single User License)
Global AI Drug Target Discovery Service Market Research Report 2026
The global AI Drug Target Discovery Service market was valued at US$ 4097 million in 2025 and is anticipated to reach US$ 17120 million by 2032, at a CAGR of 23.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 145
USD 2900.00
(Single User License)
Global AI Drug Target Discovery Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Drug Target Discovery Service market size was US$ 3394 million in 2024 and is forecast to a readjusted size of US$ 14186 million by 2031 with a CAGR of 23.0% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 114
USD 4250.00
(Single User License)
Global AI Drug Target Discovery Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Drug Target Discovery Service market is projected to grow from US$ 3394 million in 2024 to US$ 14186 million by 2031, at a CAGR of 23.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 165
USD 4900.00
(Single User License)
Global AI Drug Target Discovery Service Market Insights, Forecast to 2031
The global AI Drug Target Discovery Service market is projected to grow from US$ 4097 million in 2025 to US$ 14186 million by 2031, at a Compound Annual Growth Rate (CAGR) of 23.0% during the forecast period.
Published Date: 2025-07-02
Pages: 170
USD 4900.00
(Single User License)
Global AI Drug Target Discovery Service Market Research Report 2025
The global market for AI Drug Target Discovery Service was valued at US$ 3394 million in the year 2024 and is projected to reach a revised size of US$ 14186 million by 2031, growing at a CAGR of 23.0% during the forecast period.
Published Date: 2025-07-02
Pages: 105
USD 2900.00
(Single User License)
Global AI Drug Target Discovery Service Market Insights, Forecast to 2030
Valued at US$ 3394 million in 2024, the global AI Drug Target Discovery Service market is forecast to reach US$ 11750 million by 2030, at a CAGR of 23.0% during the forecast period.
Published Date: 2024-12-29
Pages: 116
USD 4900.00
(Single User License)
AI Drug Target Discovery Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Drug Target Discovery Service was estimated to be worth US$ 2760 million in 2023 and is forecast to a readjusted size of US$ 11750 million by 2030 with a CAGR of 23.0% during the forecast period 2024-2030.
Published Date: 2024-12-29
Pages: 96
USD 3950.00
(Single User License)

Global AI Drug Target Discovery Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI Drug Target Discovery Service market is projected to grow from US$ 4097 million in 2025 to US$ 17120 million by 2032, at a CAGR of 23.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-24
Pages: 170
USD 4900.00 (Single User License)
Global AI Drug Target Discovery Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Drug Target Discovery Service market size was US$ 4097 million in 2025 and is forecast to reach a readjusted size of US$ 17120 million by 2032 with a CAGR of 23.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 114
USD 4250.00 (Single User License)
AI Drug Target Discovery Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Drug Target Discovery Service was estimated to be worth US$ 4097 million in 2025 and is projected to reach US$ 17120 million, growing at a CAGR of 23.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 141
USD 3950.00 (Single User License)
Global AI Drug Target Discovery Service Market Research Report 2026
The global AI Drug Target Discovery Service market was valued at US$ 4097 million in 2025 and is anticipated to reach US$ 17120 million by 2032, at a CAGR of 23.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 145
USD 2900.00 (Single User License)
Global AI Drug Target Discovery Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Drug Target Discovery Service market size was US$ 3394 million in 2024 and is forecast to a readjusted size of US$ 14186 million by 2031 with a CAGR of 23.0% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 114
USD 4250.00 (Single User License)
Global AI Drug Target Discovery Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Drug Target Discovery Service market is projected to grow from US$ 3394 million in 2024 to US$ 14186 million by 2031, at a CAGR of 23.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 165
USD 4900.00 (Single User License)
Global AI Drug Target Discovery Service Market Insights, Forecast to 2031
The global AI Drug Target Discovery Service market is projected to grow from US$ 4097 million in 2025 to US$ 14186 million by 2031, at a Compound Annual Growth Rate (CAGR) of 23.0% during the forecast period.
Published: 2025-07-02
Pages: 170
USD 4900.00 (Single User License)
Global AI Drug Target Discovery Service Market Research Report 2025
The global market for AI Drug Target Discovery Service was valued at US$ 3394 million in the year 2024 and is projected to reach a revised size of US$ 14186 million by 2031, growing at a CAGR of 23.0% during the forecast period.
Published: 2025-07-02
Pages: 105
USD 2900.00 (Single User License)
Global AI Drug Target Discovery Service Market Insights, Forecast to 2030
Valued at US$ 3394 million in 2024, the global AI Drug Target Discovery Service market is forecast to reach US$ 11750 million by 2030, at a CAGR of 23.0% during the forecast period.
Published: 2024-12-29
Pages: 116
USD 4900.00 (Single User License)
AI Drug Target Discovery Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Drug Target Discovery Service was estimated to be worth US$ 2760 million in 2023 and is forecast to a readjusted size of US$ 11750 million by 2030 with a CAGR of 23.0% during the forecast period 2024-2030.
Published: 2024-12-29
Pages: 96
USD 3950.00 (Single User License)